Home › Therapeutic areas › Cardiovascular › Homozygous Familial Hypercholesterolemia

Homozygous Familial Hypercholesterolemia (1 companies)

Companies with an active program in Homozygous Familial Hypercholesterolemia.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
RARE Ultragenyx Pharmaceutical CardiovascularMetabolic+1 Rare 1 Approved $1.57B 10